07 Sep, 2017 RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyrias
On September 7, 2017, we hosted an online RNAi Roundtable to review the progress with givosiran, an RNAi therapeutic in development for the treatment of acute hepatic porphyrias.
- Jae Kim, M.D., Vice President, Clinical Development
- Moderator: Jeff Miller, General Manager, Givosiran
- Guest Speaker: Eliane Sardh, M.D., Ph.D., Porphyria Center Sweden, Karolinska University Hospital